{
    "Trade/Device Name(s)": [
        "GSP Neonatal 17\u03b1-OH-progesterone kit",
        "GSP Neonatal 17-OHP kit"
    ],
    "Submitter Information": "Wallac Oy, subsidiary of PerkinElmer",
    "510(k) Number": "K100682",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081922"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JLX"
    ],
    "Summary Letter Date": "June 3, 2010",
    "Summary Letter Received Date": "June 7, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1395"
    ],
    "Regulation Name(s)": [
        "17-Hydroxyprogesterone Test System"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "17\u03b1-OH-progesterone",
        "17-OHP"
    ],
    "Specimen Type(s)": [
        "Blood specimens dried on filter paper"
    ],
    "Specimen Container(s)": [
        "Filter paper disk",
        "Filter paper cassette (Whatman no. 903)"
    ],
    "Instrument(s)/Platform(s)": [
        "GSP Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Fluoroimmunoassay",
        "Time-resolved fluorescence"
    ],
    "Methodologies": [
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for GSP Neonatal 17\u03b1-OH-progesterone kit for quantitative determination of 17\u03b1-OH-progesterone in dried blood specimens for newborn CAH screening.",
    "Indications for Use Summary": "Intended for the quantitative determination of human 17\u03b1-OH-progesterone in blood specimens dried on filter paper as an aid in screening newborns for congenital adrenal hyperplasia (CAH) using the GSP instrument.",
    "fda_folder": "Clinical Chemistry"
}